The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D003864:Depression, Chemical; D004912:Erythrocytes / Q000276:immunology; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology*; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D008748:Methylcholanthrene; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology*; D011070:Poly I-C / Q000494:pharmacology; D011119:Polynucleotides / Q000494:pharmacology*; D011120:Polyomavirus; D011833:Radiation Injuries, Experimental / Q000276:immunology; D012756:Sheep; D016038:Skin Transplantation; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D011119:Polynucleotides; D008748:Methylcholanthrene; D011070:Poly I-C